DK694188A - Anvendelse af ace-inhibitor til laegemiddelfremstilling, evt. i kombination med et calciumkanalblokeringsmiddel - Google Patents
Anvendelse af ace-inhibitor til laegemiddelfremstilling, evt. i kombination med et calciumkanalblokeringsmiddelInfo
- Publication number
- DK694188A DK694188A DK694188A DK694188A DK694188A DK 694188 A DK694188 A DK 694188A DK 694188 A DK694188 A DK 694188A DK 694188 A DK694188 A DK 694188A DK 694188 A DK694188 A DK 694188A
- Authority
- DK
- Denmark
- Prior art keywords
- combination
- application
- pharmaceutical preparation
- blocking agent
- calcium channel
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/556—Angiotensin converting enzyme inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, ***e
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Gastroenterology & Hepatology (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13245787A | 1987-12-14 | 1987-12-14 | |
US18882788A | 1988-05-02 | 1988-05-02 |
Publications (2)
Publication Number | Publication Date |
---|---|
DK694188D0 DK694188D0 (da) | 1988-12-13 |
DK694188A true DK694188A (da) | 1989-06-15 |
Family
ID=26830371
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK694188A DK694188A (da) | 1987-12-14 | 1988-12-13 | Anvendelse af ace-inhibitor til laegemiddelfremstilling, evt. i kombination med et calciumkanalblokeringsmiddel |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0321221A3 (da) |
JP (1) | JPH0222235A (da) |
KR (1) | KR890009413A (da) |
CN (1) | CN1034312A (da) |
AU (1) | AU623615B2 (da) |
DK (1) | DK694188A (da) |
HU (1) | HU206614B (da) |
IL (1) | IL88502A (da) |
PT (1) | PT89208A (da) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU199681B (en) * | 1986-11-03 | 1990-03-28 | Sandoz Ag | Process for producing new pharmaceutical composition against hypertension and atonic cardiac decomposition |
EP0331609A3 (de) * | 1988-01-27 | 1992-07-01 | Hoechst Aktiengesellschaft | Angiotensin-Converting-Enzym-Hemmstoffe mit psychotroper Wirkung |
CA2007525A1 (en) * | 1989-01-30 | 1990-07-30 | Zola P. Horovitz | Method for facilating dieting employing an ace inhibitor |
US5093129A (en) * | 1989-01-30 | 1992-03-03 | E. R. Squibb & Sons, Inc. | Method for treating addiction to a drug of abuse employing an ace inhibitor |
US5089502A (en) * | 1989-06-02 | 1992-02-18 | E. R. Squibb & Sons, Inc. | Method for preventing or treating anxiety employing a calcium channel blocker |
WO1991002540A1 (en) * | 1989-08-16 | 1991-03-07 | Cetus Corporation | Compositions for the inhibition of protein hormone formation and uses thereof |
CA2021408A1 (en) * | 1989-08-31 | 1991-03-01 | Luana R. C. Moore | Method for treating hypermotility diseases of the bowel employing an ace inhibitor and formulation for use therein |
US6162802A (en) * | 1992-03-10 | 2000-12-19 | Papa; Joseph | Synergistic combination therapy using benazepril and amlodipine for the treatment of cardiovascular disorders and compositions therefor |
TW201039839A (en) * | 2009-03-27 | 2010-11-16 | Calpis Co Ltd | Composition for regulating antonomic nervous activity and method for regulating autonomic nervous |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4830853A (en) * | 1986-10-20 | 1989-05-16 | Warner-Lambert Company | Drug compositions stabilized against oxidation |
US4743450A (en) * | 1987-02-24 | 1988-05-10 | Warner-Lambert Company | Stabilized compositions |
CA1323833C (en) * | 1987-04-28 | 1993-11-02 | Yatindra M. Joshi | Pharmaceutical compositions in the form of beadlets and method |
-
1988
- 1988-11-25 IL IL88502A patent/IL88502A/xx unknown
- 1988-11-30 AU AU26404/88A patent/AU623615B2/en not_active Ceased
- 1988-12-13 HU HU886412A patent/HU206614B/hu not_active IP Right Cessation
- 1988-12-13 PT PT89208A patent/PT89208A/pt not_active Application Discontinuation
- 1988-12-13 DK DK694188A patent/DK694188A/da not_active Application Discontinuation
- 1988-12-13 KR KR1019880016582A patent/KR890009413A/ko not_active Application Discontinuation
- 1988-12-14 JP JP63316098A patent/JPH0222235A/ja active Pending
- 1988-12-14 EP EP19880311842 patent/EP0321221A3/en not_active Ceased
- 1988-12-14 CN CN88108574A patent/CN1034312A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
AU623615B2 (en) | 1992-05-21 |
KR890009413A (ko) | 1989-08-01 |
IL88502A (en) | 1993-04-04 |
CN1034312A (zh) | 1989-08-02 |
JPH0222235A (ja) | 1990-01-25 |
EP0321221A2 (en) | 1989-06-21 |
IL88502A0 (en) | 1989-06-30 |
EP0321221A3 (en) | 1991-04-03 |
AU2640488A (en) | 1989-06-15 |
DK694188D0 (da) | 1988-12-13 |
HUT48817A (en) | 1989-07-28 |
HU206614B (en) | 1992-12-28 |
PT89208A (pt) | 1989-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9204268A (es) | Una composicion para la liberacion prolongada y controlada de substancias medicamentosas y un proceso para preparar la misma. | |
DK0450141T4 (da) | Bærermateriale til administrering af lægemidler | |
FI895681A0 (fi) | Farmaceutisk komposition foer systemisk transdermal tillfoersel. | |
NO20053106D0 (no) | Oral, analgesisk doseringsform med forlenget frigivelse. | |
EE9700241A (et) | Farmatseutiline kompositsioon transdermaalseks manustamiseks | |
DE3778106D1 (de) | Dosierungsform mit verzoegernder freisetzung. | |
NO891893L (no) | Sementblanding med to faser. | |
IT1235532B (it) | Composti carbossiammidici, procedimenti per la preparazione dei medesimi e composizione farmaceutica contenente i medesimi | |
IT8323205A0 (it) | Composizioni farmaceutiche adattivita' antiinfiammatoria e/o analgesica, non ulcerogene. | |
DE69725860D1 (de) | PLAN ZUR VERABREICHUNG VON H+, K+-ATPase INHIBITOREN | |
ES2042776T3 (es) | Un procedimiento para la preparacion de una composicion farmaceutica. | |
DK694188A (da) | Anvendelse af ace-inhibitor til laegemiddelfremstilling, evt. i kombination med et calciumkanalblokeringsmiddel | |
DK23790D0 (da) | Doseringsform til administrering af en calciumantagonist | |
ZA898201B (en) | Gestodene-containing agent for transdermal administration | |
DK665489A (da) | Fremgangsmaade til fremstilling af mono-n-alkylerede polyazamakrocykliske forbindelser | |
DK226488A (da) | Anvendelse af ace-inhibitorer til fremstilling af farmaceutiske praeparater | |
DK586188D0 (da) | Kondenserede diazepinoner, fremgangsmaade til deres fremstilling og laegemidler med indhold af saadanne forbindelser | |
DK99989D0 (da) | Anvendelse af ace-inhibitorer til fremstilling af laegemiddel med profylaktisk virkning mod diabetes | |
DK524489D0 (da) | Fremgangsmaade til fremstilling af biologisk aktive forbindelser, specielt enzymer | |
DK291189A (da) | Kondenserede diazepinoner, fremgangsmaade til fremstilling af saadanne forbindelser og laegemidler med indhold af forbindelserne | |
ATE71535T1 (de) | Pharmazeutische zubereitungen. | |
BR9809478A (pt) | Uso de um oligossacarìdeo sintético, processos para prevenção de coagulação sanguìnea em um mamìfero e para prevenção de coagulação sanguìnea e um circuito sanguìneo extracorpóreo, e, composição farmacêutica adaptada para prevenir coagulação sanguìnea em um circuito sanguìneo extracorpóreo | |
DK524889A (da) | Anvendelse af en ace-inhibitor, evt. i kombination med et thrombolytisk middel, til fremstilling af et farmaceutisk praeparat til forbedring af post-ischaemisk myocardial dysfunktion | |
AR240017A1 (es) | Procedimiento de preparacion de una composicion farmaceutica para absorcion percutanea. | |
HU9501218D0 (en) | Use of bhap compounds in combination with other non-nucleoside reverse transcriptase inhibitors for the treatment of hiv infection |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AHB | Application shelved due to non-payment |